Cardiac resynchronization therapy contraindications: Difference between revisions
(/* 2012 American College of Cardiology Foundation/American Heart Association Task Force/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities {{cite web |url=http://content.onlinejacc.org/article.aspx?a...) |
No edit summary |
||
| Line 18: | Line 18: | ||
'''2)''' CRT is not indicated for patients whose comorbidities and/or frailty limit survival with good functional capacity to less than 1 year. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) | '''2)''' CRT is not indicated for patients whose comorbidities and/or frailty limit survival with good functional capacity to less than 1 year. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) | ||
}} | }} | ||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 13:20, 12 September 2012
|
Cardiac resynchronization therapy Microchapters |
|
Treatment |
|---|
|
Cardiac resynchronization therapy contraindications On the Web |
|
American Roentgen Ray Society Images of Cardiac resynchronization therapy contraindications |
|
Cardiac resynchronization therapy contraindications in the news |
|
Blogs on Cardiac resynchronization therapy contraindications |
|
Directions to Hospitals Administering Cardiac resynchronization therapy |
|
Risk calculators and risk factors for Cardiac resynchronization therapy contraindications |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:: Bhaskar Purushottam, M.D. [2] Synonyms and Keywords: CRT
Overview
CRT is contraindicated in patients who are symptomatic or who have a limited life expectancy.
Contraindications
- Patients who are asymptomatic with a reduced LVEF who have no other indications for pacing.
- Patients who have a limited life expectancy due to a non-cardiac condition.
- Patients who have a limited functional capacity due to a chronic non-cardiac condition.
2012 American College of Cardiology Foundation/American Heart Association Task Force/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities [1] (DO NOT EDIT)
| “ |
Class III1) CRT is not recommended for patients with NYHA class I or II symptoms and non-LBBB pattern with QRS duration less than 150 ms. (Level of Evidence: B) 2) CRT is not indicated for patients whose comorbidities and/or frailty limit survival with good functional capacity to less than 1 year. (Level of Evidence: C)
|
” |
References
- ↑ "American College of Cardiology Foundation | Journal of the American College of Cardiology | 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Retrieved 2012-09-11.